Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) Shares Outstanding (Weighted Average) (2016 - 2025)

Collegium Pharmaceutical has reported Shares Outstanding (Weighted Average) over the past 10 years, most recently at $31.7 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $31.7 million for Q4 2025, down 1.76% from a year ago — trailing twelve months through Dec 2025 was $31.7 million (down 1.76% YoY), and the annual figure for FY2025 was $31.7 million, down 1.76%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $31.7 million at Collegium Pharmaceutical, roughly flat from $31.6 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for COLL hit a ceiling of $35.4 million in Q3 2021 and a floor of $31.6 million in Q3 2025.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $33.7 million (2023), compared with a mean of $33.4 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): rose 2.64% in 2021 and later fell 6.32% in 2024.
  • Collegium Pharmaceutical's Shares Outstanding (Weighted Average) stood at $34.9 million in 2021, then dropped by 3.17% to $33.8 million in 2022, then dropped by 0.26% to $33.7 million in 2023, then fell by 4.35% to $32.3 million in 2024, then fell by 1.76% to $31.7 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $31.7 million (Q4 2025), $31.6 million (Q3 2025), and $31.8 million (Q2 2025) per Business Quant data.